SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-19-122478
Filing Date
2019-04-26
Accepted
2019-04-26 16:34:46
Documents
44
Reference 429
333-198800

Document Format Files

Seq Description Document Type Size
1 POS AM d716587dposam.htm POS AM 1071470
2 EX-23.1 d716587dex231.htm EX-23.1 1588
9 GRAPHIC g716587g30f43.jpg GRAPHIC 10479
  Complete submission text file 0001193125-19-122478.txt   4584492

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT hppi-20181231.xml EX-101.INS 1052964
4 XBRL TAXONOMY EXTENSION SCHEMA hppi-20181231.xsd EX-101.SCH 33702
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20181231_cal.xml EX-101.CAL 24062
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20181231_def.xml EX-101.DEF 169908
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20181231_lab.xml EX-101.LAB 281727
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20181231_pre.xml EX-101.PRE 225404
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-212092 | Film No.: 19772206
SIC: 8731 Services-Commercial Physical & Biological Research